Why Is Aducanumab Priced at $56,000 per Patient? Lessons for Drug-Pricing Reform

N Engl J Med. 2021 Nov 25;385(22):2017-2019. doi: 10.1056/NEJMp2113679. Epub 2021 Nov 20.
No abstract available

MeSH terms

  • Alzheimer Disease / drug therapy
  • Antibodies, Monoclonal, Humanized / economics*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Cost Sharing / economics
  • Drug Costs*
  • Drug Industry / economics*
  • Health Care Reform / economics
  • Humans
  • Infusions, Intravenous / economics
  • Insurance Carriers / economics*
  • Medicare / economics*
  • Reimbursement Mechanisms / economics*
  • United States

Substances

  • Antibodies, Monoclonal, Humanized
  • aducanumab